Lawmakers Consider New Measures as China's Biotech Sector Expands
Despite existing biosecurity measures, China's biotechnology sector continues to grow, prompting some lawmakers to propose additional legislation and regulations.
Editorial Staff
1 min read
Updated 4 days ago
China's biotechnology industry has seen significant growth, raising concerns among some U.S. lawmakers about the implications for domestic biopharma companies.
In response, these lawmakers are reportedly laying the groundwork for new legislation and regulations aimed at countering the influence of Chinese biopharma firms.
The discussions highlight ongoing tensions and the complexities of managing international competition in the biotech sector.